Clinical Trial Update: To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial investigating UB-421 monotherapy for HIV-1 infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United BioPharma | Conditions: HIV-1 Infection | Phase 3 | Status: WITHDRAWN